Adenosine 5'-diphosphate (potassium salt hydrate)
(Synonyms: 5'-ADP, ADP) 目录号 : GC46806A neuropeptide with diverse biological activities
Sample solution is provided at 25 µL, 10mM.
Adenosine 5'-diphosphate (ADP) is an adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5' position. It is produced by dephosphorylation of adenosine 5'-triphosphate by ATPases and can be converted back to ATP by ATP synthases. ADP can also be metabolized to adenosine 5'-monophosphate and 2'-deoxyadenosine 5'-diphosphate (dADP). ADP can modulate several receptors, activating certain purinergic receptors (EC50 = 24 nM for P2Y1) and inhibiting others (IC50 = 67 nM for P2X2/3), inhibiting rat ecto-5'nucleotidase (Ki = 0.91 nM), and regulating the phosphorylation status of AMP-activated protein kinase (AMPK).1,2,3,4
1.Azran, S., FÖrster, D., Danino, O., et al.Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonistsJ. Med. Chem.56(12)4938-4952(2013) 2.Baqi, Y., Lee, S.-Y., Iqbal, J., et al.Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffoldJ. Med. Chem.53(5)2076-2086(2010) 3.Jarvis, M.F., Bianchi, B., Uchic, J.T., et al.[3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptorsJournal of Pharmacology and Experimental Therapeutics310(1)407-416(2004) 4.Ruderman, N.B., Carling, D., Prentki, M., et al.AMPK, insulin resistance, and the metabolic syndromeJ. Clin. Invest.123(7)2764-2772(2013)
Cas No. | N/A | SDF | |
别名 | 5'-ADP, ADP | ||
Canonical SMILES | O[C@H]1[C@H](N2C=NC3=C2N=CN=C3N)O[C@H](COP(OP(O)(O)=O)(O)=O)[C@H]1O.[K].O | ||
分子式 | C10H15N5O10P2.K [XH2O] | 分子量 | 466.3 |
溶解度 | PBS (pH 7.2): 10 mg/mL | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.1445 mL | 10.7227 mL | 21.4454 mL |
5 mM | 0.4289 mL | 2.1445 mL | 4.2891 mL |
10 mM | 0.2145 mL | 1.0723 mL | 2.1445 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet